Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sichuan Univ. MAO-B compound 7d
- Development stage
- Unknown
- Lead developer
- Sichuan University
01
Overview
Sichuan Univ. MAO-B compound 7d: sourced facts only. name: "Among them, compound 7d was the most potent agent with excellent inhibitory activities on EeAChE (IC50 = 0.087 μM), HuAChE (IC50 = 0.041 μM) and MAO-B (IC50 = 0.30 μM)." [PMID:35183029]; target: "Among them, compound 7d was the most potent agent with excellent inhibitory activities on EeAChE (IC50 = 0.087 μM), HuAChE (IC50 = 0.041 μM) and MAO-B (IC50 = 0.30 μM)." [PMID:35183029]; developer: "Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, Chengdu 610041, China." [PMID:35183029]
02
Targets
MAOB (Monoamine oxidase B)
Beyond the preview
Go deeper on Sichuan Univ. MAO-B compound 7d.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sichuan Univ. MAO-B compound 7d.